Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Amortizatization of Intangibles (2022 - 2025)

Treace Medical Concepts (TMCI) has disclosed Amortizatization of Intangibles for 4 consecutive years, with $4000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Amortizatization of Intangibles fell 98.24% year-over-year to $4000.0, compared with a TTM value of $123000.0 through Dec 2025, down 89.26%, and an annual FY2025 reading of $123000.0, down 89.26% over the prior year.
  • Amortizatization of Intangibles was $4000.0 for Q4 2025 at Treace Medical Concepts, down from $5000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $375000.0 in Q4 2023 and bottomed at $4000.0 in Q4 2025.
  • Average Amortizatization of Intangibles over 4 years is $215384.6, with a median of $233000.0 recorded in 2024.
  • The sharpest move saw Amortizatization of Intangibles skyrocketed 197.62% in 2023, then tumbled 98.24% in 2025.
  • Year by year, Amortizatization of Intangibles stood at $126000.0 in 2022, then surged by 197.62% to $375000.0 in 2023, then plummeted by 39.47% to $227000.0 in 2024, then crashed by 98.24% to $4000.0 in 2025.
  • Business Quant data shows Amortizatization of Intangibles for TMCI at $4000.0 in Q4 2025, $5000.0 in Q3 2025, and $37000.0 in Q2 2025.